Stryker price target raised to $313 from $299 at BTIG

BTIG raised the firm’s price target on Stryker to $313 from $299 and keeps a Buy rating on the shares. The company’s Q1 results were "strong", but the bar was also high with whisper estimates looking for 13% organic growth – well above the Street’s 8%, the analyst tells investors in a research note. Stryker looks to be benefiting from improving end-markets, healthy order demand, and new product cycles, BTIG adds, stating that it would be a buyer on any weakness as shares pulled back after-hours on a combination of high expectations and a lack of margin pull-through.